Progressive Macrocytic Anemia Over 14 Years Leading to the Diagnosis of VEXAS Syndrome in a Patient Initially Diagnosed With Adult-Onset Still’s Disease: A Case Report
Clicks: 1
ID: 320748
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #41 of 46 articles by views in Modern Rheumatology Case Reports
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a recently recognized autoinflammatory disease caused by somatic mutations in UBA1. Its clinical features include recurrent fever, systemic inflammation affecting multiple organs, and progressive hematologic abnormalities such as macrocytic anemia. Because these manifestations overlap with other autoinflammatory diseases, including adult-onset Still's disease (AOSD), the diagnosis can be challenging. In this case report, we describe a patient initially diagnosed with AOSD who was ultimately found to have VEXAS syndrome five years later due to progressive macrocytic anemia. The patient developed recurrent fever and skin rash but did not have macrocytic anemia at onset. Over the subsequent five years, his mean corpuscular volume progressively increased. Bone marrow biopsy revealed no evidence of malignancy but showed vacuoles in myeloid and erythroid progenitor cells. Based on these findings, VEXAS syndrome was suspected, and UBA1 testing identified the pathogenic p.Met41Thr variant, confirming the diagnosis. This case highlights that macrocytic anemia may not be present in the early phase of VEXAS syndrome. In patients diagnosed with AOSD who later develop or progressively worsen macrocytic anemia, clinicians should consider VEXAS syndrome and perform UBA1 variant testing.
| Reference Key |
openalex_W7168105954
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Kazuya Abe, Kentaro Takahashi, Ayako Matsuki, Yoshitaka Zaimoku, Takeshi Umibe |
| Journal | Modern Rheumatology Case Reports |
| Year | 2026 |
| DOI |
10.1093/mrcr/rxag067
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.